The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Global Antipsychotic Drugs Market 2021-2027
US$ 2,240.00
Antipsychotic drugs, also known as neuroleptics, are a class of psychotropic medication primarily used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorder...
February 2022
76 pages
DNA Repair Drugs: Global Markets
US$ 5,500.00
Report : This report provides an in-depth examination of the healthcare industry, with a particular emphasis on global market trend analysis. The report's goal is to provide an overview of the market...
February 2022
112 pages
Complement Inhibitors Market: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis Optica and Paroxysmal Nocturnal Hemoglobinuria), Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Oral and Subcutaneous), Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The projected value of complement inhibitors market is expected to be valued at USD 6,800 million in 2022 and is anticipated to grow at a CAGR of 15% during the forecast period 2022-2035. Since the ap...
February 2022
131 pages
Global Alzheimer Drugs Market (2022 Edition) – Analysis By Drug Class (Cholinergic, Memantine, Combined Drugs, Others), Distribution Channel, By Region, By Country: Market Insights, Pipeline and Forecast with Impact of Covid-19 (2022-2027)
US$ 2,400.00
Executive According to Azoth Analytics research report, the Global Alzheimer Drugs Market was valued at USD 6537.0 Million in the year 2021. Diabetes, obesity, heart diseases and high blood pressure...
January 2022
220 pages
Colon Cancer (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Colon Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer – Drugs In Development, 2021, provides an...
December 2021
1498 pages
Medulloblastoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Medulloblastoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Medulloblastoma – Drugs In Development, 2021, provid...
December 2021
556 pages
Meningitis (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Meningitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meningitis – Drugs In Development, 2021, provid...
December 2021
89 pages
Ovarian Cancer (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Ovarian Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Drugs In Development, 2021, provides...
December 2021
5066 pages
Presbyopia (Ophthalmology) - Drugs in Development, 2021
US$ 2,000.00
Presbyopia (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Presbyopia – Drugs In Development, 2021, provides an...
December 2021
78 pages
